Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Aly Ahmed A. Rahim"'
Autor:
Sanjay Kalra, Silver Bahendeka, Rakesh Sahay, Sujoy Ghosh, Fariduddin Md, Abbas Orabi, Kaushik Ramaiya, Sameer Al Shammari, Dina Shrestha, Khalid Shaikh, Sachitha Abhayaratna, Pradeep K Shrestha, Aravinthan Mahalingam, Mazen Askheta, Aly Ahmed A. Rahim, Fatimah Eliana, Hari K Shrestha, Sandeep Chaudhary, Nancy Ngugi, Jean Claude Mbanya, Than Than Aye, Tint Swe Latt, Zhanay A Akanov, Abbas Raza Syed, Nikhil Tandon, A G Unnikrishnan, S V Madhu, Ali Jawa, Subhankar Chowdhury, Sarita Bajaj, Ashok Kumar Das
Publikováno v:
Indian Journal of Endocrinology and Metabolism, Vol 22, Iss 1, Pp 132-157 (2018)
For decades, sulfonylureas (SUs) have been important drugs in the antidiabetic therapeutic armamentarium. They have been used as monotherapy as well as combination therapy. Focus on newer drugs and concerns about the risk of severe hypoglycemia and w
Externí odkaz:
https://doaj.org/article/73a735d668e9491791f0aafe96c47203
Autor:
Sanjay Kalra, Silver Bahendeka, Rakesh Sahay, Sujoy Ghosh, Fariduddin Md, Abbas Orabi, Kaushik Ramaiya, Sameer Al Shammari, Dina Shrestha, Khalid Shaikh, Sachitha Abhayaratna, Pradeep K Shrestha, Aravinthan Mahalingam, Mazen Askheta, Aly Ahmed A. Rahim, Fatimah Eliana, Hari K Shrestha, Sandeep Chaudhary, Nancy Ngugi, Jean Claude Mbanya, Than Than Aye, Tint Swe Latt, Zhanay A Akanov, Abbas Raza Syed, Nikhil Tandon, A G Unnikrishnan, S V Madhu, Ali Jawa, Subhankar Chowdhury, Sarita Bajaj, Ashok Kumar Das, N Hegde Shrikanth
Publikováno v:
APIK Journal of Internal Medicine, Vol 7, Iss 1, Pp 61-63 (2019)
Externí odkaz:
https://doaj.org/article/b9a6c769e22442edb70dc8bd135a0eee
Autor:
Amaya Joshi, Sruti Chandrasekaran, Abbas Orabi, Fatimah Eliana, Parag Shah, M. D. Fariduddin, Ahamed Shaheed, Shayaminda Kahandawa, Debmalya Sanyal, Sujoy Ghosh, Khalid Shaikh, R. N. Mehrotra, Sanjay Kalra, Pradeep Krishna Shrestha, A K Das, Dina Shrestha, Sambit Das, Wiam I. Hussein, Gagan Priya, Ahmed Al-Ani, Aly Ahmed Abdel Rahim, Tiny Nair, Manilka Sumanathilaka, V D Deshmukh, Dinesh Kumar, Sarita Bajaj, Hikmat Permana, Deepak Khandelwal
Publikováno v:
Diabetes Therapy
Aim The primary objective of this review is to develop a practice-based expert group opinion on the role of precision medicine with a specific focus on sulfonylureas (SUs) in diabetes management. Background The clinical etiology, presentation and com
Autor:
Sanjay Kalra, Dina Shreshtha, Mimi Giri, Silver Bahendeka, Shyaminda Kahandawa, M. P. Baruah, Surender Singh, Ketut Suastika, Moosa Murad, Sambit Das, Faria Afsana, Shajada Selim, Arundhati Dasgupta, Aly Ahmed Abdul Rahim, Kaushik Ramaiya, Fariduddin Mohammed, Ahmed Al-Ani, Fatimah Eliana, Syed Abbas Raza, Abdurezak Ahmed Abdela, Manoj Chawla, Charlotte Bavuma, Mangesh Tiwaskar, Sundeep Ruder, Muaz Moosa, Chaminda Garusinghe, AG Unnikrishnan, Pradeep Krishna Shreshtha, Dimuthu Muthukuda, Parag Shah, Muhammed Hafizur Rahman, Than Than Aye, Manish Khanolkar, Abbas Orabi, Muditha Weerakkody, Koy Vanny, Rishi Shukla, Leszek Czupryniak, Andrew Uloko, Faruque Pathan, Rakesh Sahay, Wiam Hussain, A K Das, G. Vijayakumar
Publikováno v:
Diabetes Therapy
Aim The primary objective of this document is to develop practice-based expert group opinion on certain important but less discussed endocrine and metabolic effects of modern sulfonylureas (SUs) and their usage in the management of diabetes mellitus
Autor:
Abbas Raza Syed, Aly Ahmed Abdul Rahim, Sameer Al Shammari, Dina Shrestha, AG Unnikrishnan, Abbas Orabi, Khalid Shaikh, Nikhil Tandon, Jean Claude Mbanya, Sachitha Abhayaratna, Sandeep Chaudhary, Sri Venkata Madhu, Hari Kumar Shrestha, Rakesh Sahay, Sanjay Kalra, Tint Swe Latt, Fatimah Eliana, Sarita Bajaj, Ashok Kumar Das, Zhanay Akanov, Sujoy Ghosh, Aravinthan Mahalingam, Subhankar Chowdhury, Than Than Aye, Pradeep Krishna Shrestha, Mazen Askheta, Nancy Ngugi, Fariduddin, Ali Jawa, Kaushik Ramaiya, Silver Bahendeka
Publikováno v:
Indian Journal of Endocrinology and Metabolism, Vol 22, Iss 1, Pp 132-157 (2018)
Indian Journal of Endocrinology and Metabolism
Indian Journal of Endocrinology and Metabolism
For decades, sulfonylureas (SUs) have been important drugs in the antidiabetic therapeutic armamentarium. They have been used as monotherapy as well as combination therapy. Focus on newer drugs and concerns about the risk of severe hypoglycemia and w
Autor:
Ansumali Joshi, Aly Ahmed Abdel Rahim, Shyaminda Kahandawa, Shreeparna Ghosh, Deepak Khandelwal, Dinesh Kumar, Gagan Priya, A. Shaheed, M. Chawla, Hikmat Permana, R. N. Mehrotra, Sanjay Kalra, Debmalya Sanyal, Khalid Shaikh, Manilka Sumanathilaka, Parag Shah, Sarita Bajaj, Pradeep Krishna Shrestha, V D Deshmukh, A K Das, Sambit Das, Sruti Chandrasekaran, Ahmed Al-Ani, Wiam I. Hussein, M. D. Fariduddin, Tiny Nair, Dina Shrestha, Fatimah Eliana, Abbas Orabi
Publikováno v:
Indian Heart Journal
Indian Heart Journal, Vol 72, Iss 1, Pp 7-13 (2020)
Indian Heart Journal, Vol 72, Iss 1, Pp 7-13 (2020)
Aim The primary objective of this review is to develop practice-based expert group opinions on the cardiovascular (CV) safety and utility of modern sulfonylureas (SUs) in cardiovascular outcome trials (CVOTs). Background The United States Food and Dr
Autor:
Debmalya Sanyal, Khalid Shaikh, Aly Ahmed Abdel Rahim, Abbas Orabi, Shreeparna Ghosh, Ahmed Al-Ani, Gagan Priya, Fatimah Eliana, Hikmat Permana, Deepak Khandelwal, Dina Shrestha, R. N. Mehrotra, Sruti Chandrasekaran, Tiny Nair, Manilka Sumanathilaka, Sanjay Kalra, Sarita Bajaj, A. Shaheed, Wiam I. Hussein, V D Deshmukh, Dinesh Kumar, Fariduddin, A K Das, Ansumali Joshi, Shyaminda Kahandawa, Pradeep Krishna Shrestha, Sambit Das, Parag Shah
Publikováno v:
Journal of Family Medicine and Primary Care
Journal of Family Medicine and Primary Care, Vol 9, Iss 11, Pp 5450-5457 (2020)
Journal of Family Medicine and Primary Care, Vol 9, Iss 11, Pp 5450-5457 (2020)
Type 2 diabetes mellitus (T2DM) is a progressive disease with multifactorial etiology. The first-line therapy includes monotherapy (with metformin), which often fails to provide effective glycemic control, necessitating the addition of add-on therapy
Autor:
Nabil A El Kafrawy, Abbas Orabi, Ihab Attia, Mohamed Kamar, Sherif Hafez, Farouk Koura, Mohamed Hesham Mohamed Fahmy El Hefnawy, Mohamed Fahmy Abdel Aziz, Adel El Etriby, Fahmy Amara, Mohamed Shawky El-Sayed, Hanan Gawish, Farouk Talaat, Aly Ahmed Abdel Rahim, Ebtissam Zakaria, Samir N Assaad, Mohamed Reda Halawa, Samir Helmy Assaad Khalil
Publikováno v:
Current Diabetes Reviews
Diabetic polyneuropathy (DPN) is a complex and multifactorial entity in which various factors besides hyperglycemia play an important role. Symptoms of DPN are sensory, motor or autonomic. Intensive research proved that oxidative stress is the common